1296269-73-2Relevant articles and documents
Mutant type IDH inhibitors, preparation method thereof, and pharmaceutical composition containg the same as an active ingredient
-
Paragraph 0578-0580, (2021/05/18)
The present invention is a mutated IDH1 inhibitor. The present invention relates to a compound represented by chemical formula 1, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof according to the present invention, which has excellent inhibitory activity against mutated IDH1 and can reduce intracellular tumor-induced metabolite (2-HG), and a health functional food composition for preventing or IDH1 treating cancer, comprising the same as an active ingredient.